ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011